The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
Open accessAbstract
Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail. In vitro, most VRE remain susceptible to last-resort antibiotics such as linezolid, tigecycline and daptomycin. However, neither tigecycline nor linezolid act in a bactericidal manner, and daptomycin has proven activity only at high dosages licensed for treating enterococcal endocarditis. Despite these pharmacological and therapeutic limitations, reports on resistance to these last-resort drugs in VRE, and enterococci in general, have increased in recent years. In this review, we briefly recapitulate the current knowledge on the mode of action as well as the known and novel mechanisms of resistance and describe surveillance data on resistance to linezolid, tigecycline and daptomycin in enterococci. In addition, we also suggest a common nomenclature for designating enterococci and VRE with resistances to these important last-resort antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 1×
“…synthesis at the elongation stage by preventing the binding of the ternary complex amino acid-tRNA·EF-Tu·GTP to the small 30S ribosomal subunit (Brodersen et al., 2000; Chopra and Roberts, 2001; Pioletti et al., 2001) due to an overlap in the primary binding site (named Tet-1) with the…”
BackgroundEnterococci as probiotics and their implications in food safety
Franz, C. M. A. P., Huch, M., Abriouel, H., Holzapfel, W., & Gálvez, A. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.08.014 · Cited by 788
Mechanisms of antibiotic resistance in enterococci
Miller, W. R., Munita, J. M., & Arias, C. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.956092 · Cited by 772
Tetracycline Antibiotics and Resistance
Grossman, T. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025387 · Cited by 725
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
Swaney, S. M., Aoki, H., Ganoza, M. C., & Shinabarger, D. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3251 · Cited by 555
Wang, Y., Lv, Y., Cai, J., Schwarz, S., Cui, L., Hu, Z., Zhang, R., Li, J., Zhao, Q., He, T., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv116 · Cited by 546
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542
Emergence and spread of vancomycin resistance among enterococci in Europe
Werner, G., Coque, T. M., Hammerum, A. M., Hope, R., Hryniewicz, W., Johnson, A., Klare, I., Kristinsson, K. G., Leclercq, R., Lester, C. H., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19046-en · Cited by 539
Self-citationCrystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1829 · Cited by 527
Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains
Lebreton, F., van Schaik, W., Manson McGuire, A., Godfrey, P., Griggs, A., Mazumdar, V., Corander, J., Cheng, L., Saif, S., Young, S., et al. (2013) · mBio · doi:10.1128/mbio.00534-13 · Cited by 455
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Thaker, M., Spanogiannopoulos, P., & Wright, G. D. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0172-6 · Cited by 378
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377
Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G., & Sundsfjord, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03226.x · Cited by 359
Self-citationHigh-level vancomycin-resistant enterococci causing hospital infections
Uttley, A. H. C., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., & Heptonstall, J. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030478 · Cited by 343
Schwarz, S., Werckenthin, C., & Kehrenberg, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2530-2533.2000 · Cited by 341
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
Pankey, G. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki248 · Cited by 301
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Microbial genome-wide association studies: lessons from human GWAS
Power, R. A., Parkhill, J., & de Oliveira, T. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.132 · Cited by 289
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.972-978.2003 · Cited by 286 · cited 1×
“aeruginosa and Proteus mirabilis show an intrinsic reduced susceptibility to TGC associated with the expression of MexXY-OprM and AcrAB-TolC RND-type systems, respectively (Dean et al., 2003; Visalli et al., 2003).”
BackgroundKaatz, G. W., McAleese, F., & Seo, S. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1857-1864.2005 · Cited by 279
Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
Shen, J., Wang, Y., & Schwarz, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt092 · Cited by 258
Antonelli, A., D’Andrea, M. M., Brenciani, A., Galeotti, C. L., Morroni, G., Pollini, S., Varaldo, P. E., & Rossolini, G. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky088 · Cited by 257
Resistance to vancomycin and teicoplanin: an emerging clinical problem
Johnson, A. P., Uttley, A. H., Woodford, N., & George, R. C. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.3.280 · Cited by 245
Nosocomial Spread of Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium
Herrero, I. A., Issa, N. C., & Patel, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200203143461121 · Cited by 241
A Current Perspective on Daptomycin for the Clinical Microbiologist
Humphries, R. M., Pollett, S., & Sakoulas, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-13 · Cited by 240
Mechanisms of drug resistance: daptomycin resistance
Tran, T. T., Munita, J. M., & Arias, C. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12948 · Cited by 234
McAleese, F., Petersen, P., Ruzin, A., Dunman, P. M., Murphy, E., Projan, S. J., & Bradford, P. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1865-1871.2005 · Cited by 233
Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 227
Mendes, R. E., Deshpande, L. M., & Jones, R. N. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.04.002 · Cited by 221
Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetX
Moore, I. F., Hughes, D. W., & Wright, G. D. (2005) · Biochemistry · doi:10.1021/bi0506066 · Cited by 217
Kloss, P., Xiong, L., Shinabarger, D. L., & Mankin, A. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3247 · Cited by 213
Functional, biophysical, and structural bases for antibacterial activity of tigecycline
Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S., O'Connell, J., & Bradford, P. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01499-05 · Cited by 207
Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., & Wilkinson, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01121-07 · Cited by 205
Jenner, L., Starosta, A. L., Terry, D. S., Mikolajka, A., Filonava, L., Yusupov, M., Blanchard, S. C., Wilson, D. N., & Yusupova, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216691110 · Cited by 204
Restricted Gene Flow among Hospital Subpopulations of Enterococcus faecium
Willems, R. J. L., Top, J., van Schaik, W., Leavis, H., Bonten, M., Sirén, J., Hanage, W. P., & Corander, J. (2012) · mBio · doi:10.1128/mbio.00151-12 · Cited by 204
DEBONO, M., ABBOTT, B. J., MOLLOY, R. M., FUKUDA, D. S., HUNT, A. H., DAUPERT, V. M., COUNTER, F. T., OTT, J. L., CARRELL, C. B., HOWARD, L. C., et al. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.1093 · Cited by 203
Brickner, S. J., Barbachyn, M. R., Hutchinson, D. K., & Manninen, P. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800038g · Cited by 196
Tran, T. T., Panesso, D., Mishra, N. N., Mileykovskaya, E., Guan, Z., Munita, J. M., Reyes, J., Diaz, L., Weinstock, G. M., Murray, B. E., et al. (2013) · mBio · doi:10.1128/mbio.00281-13 · Cited by 192
Genetic Basis for Daptomycin Resistance in Enterococci
Palmer, K. L., Daniel, A., Hardy, C., Silverman, J., & Gilmore, M. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-11 · Cited by 189
Antibiotic resistant enterococci—Tales of a drug resistance gene trafficker
Werner, G., Coque, T. M., Franz, C. M. A. P., Grohmann, E., Hegstad, K., Jensen, L., van Schaik, W., & Weaver, K. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.03.001 · Cited by 186
Self-citationThe emergence of clinical resistance to tigecycline
Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 185
Stein, G. E., & Babinchak, T. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.004 · Cited by 183
The Tetracycline Destructases: A Novel Family of Tetracycline-Inactivating Enzymes
Forsberg, K. J., Patel, S., Wencewicz, T. A., & Dantas, G. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.017 · Cited by 181
Diaz, L., Kiratisin, P., Mendes, R. E., Panesso, D., Singh, K. V., & Arias, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00419-12 · Cited by 181
Mishra, N. N., Bayer, A. S., Tran, T. T., Shamoo, Y., Mileykovskaya, E., Dowhan, W., Guan, Z., & Arias, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043958 · Cited by 168
Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin
Hachmann, A.-B., Angert, E. R., & Helmann, J. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01329-08 · Cited by 167
Visalli, M. A., Murphy, E., Projan, S. J., & Bradford, P. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.665-669.2003 · Cited by 165 · cited 1×
“Of note, both P. aeruginosa and Proteus mirabilis show an intrinsic reduced susceptibility to TGC associated with the expression of MexXY-OprM and AcrAB-TolC RND-type systems, respectively (Dean et al., 2003; Visalli et al., 2003).”
BackgroundPotential of Tetracycline Resistance Proteins To Evolve Tigecycline Resistance
Linkevicius, M., Sandegren, L., & Andersson, D. I. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02465-15 · Cited by 165
Bauer, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh125 · Cited by 163
Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
Zhang, T., Muraih, J. K., Tishbi, N., Herskowitz, J., Victor, R. L., Silverman, J., Uwumarenogie, S., Taylor, S. D., Palmer, M., & Mintzer, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554444 · Cited by 162
Bergeron, J., Ammirati, M., Danley, D., James, L., Norcia, M., Retsema, J., Strick, C. A., Su, W. G., Sutcliffe, J., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2226 · Cited by 157
He, T., Shen, Y., Schwarz, Š., Cai, J., Lv, Y., Li, J., Feßler, A. T., Zhang, R., Wu, C., Shen, J., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw016 · Cited by 155
Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program
Mutnick, A. H., Enne, V., & Jones, R. N. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c437 · Cited by 152
Deshpande, L. M., Ashcraft, D. S., Kahn, H. P., Pankey, G. A., Jones, R. N., Farrell, D. J., & Mendes, R. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-15 · Cited by 150
Oligomerization of daptomycin on membranes
Muraih, J. K., Pearson, A. L., Silverman, J. A., & Palmer, M. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.01.001 · Cited by 149
The emerging problem of linezolid-resistant enterococci
Bi, R., Qin, T., Fan, W., Ma, P., & Gu, B. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.10.018 · Cited by 148
Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs
Díaz, L., Tran, T. T., Munita, J. M., Miller, W. R., Rincón, S., Carvajal, L. P., Wollam, A., Reyes, J., Panesso, D., Rojas, N. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02686-14 · Cited by 143
Fiedler, S., Bender, J. K., Klare, I., Halbedel, S., Grohmann, E., Szewzyk, U., & Werner, G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv420 · Cited by 140
Self-citationVilla, L., Feudi, C., Fortini, D., García-Fernández, A., & Carattoli, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01803-13 · Cited by 138
First Report of the Multidrug Resistance Gene cfr in Enterococcus faecalis of Animal Origin
Liu, Y., Wang, Y., Wu, C., Shen, Z., Schwarz, Š., Du, X., Dai, L., Zhang, W., Zhang, Q., & Shen, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06091-11 · Cited by 134
The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
Beabout, K., Hammerstrom, T. G., Perez, A. M., Magalhães, B. D. F., Prater, A. G., Clements, T. P., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-15 · Cited by 129
Rahim, S., Pillai, S. K., Gold, H. S., Venkataraman, L., Inglima, K., & Press, R. A. (2003) · Clinical Infectious Diseases · doi:10.1086/374929 · Cited by 129
Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
Cotroneo, N. S., Harris, R. J., Perlmutter, N. G., Beveridge, T. J., & Silverman, J. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-07 · Cited by 127
Tran, T. T., Panesso, D., Gao, H., Roh, J. H., Munita, J. M., Reyes, J., Diaz, L., Lobos, E. A., Shamoo, Y., Mishra, N. N., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-12 · Cited by 125
Kuch, A., Willems, R. J. L., Werner, G., Coque, T. M., Hammerum, A. M., Sundsfjord, A., Klare, I., Ruíz-Garbajosa, P., Simonsen, G. S., van Luit‐Asbroek, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr544 · Cited by 120
Self-citationLi, D., Wang, Y., Schwarz, Š., Cai, J., Fan, R., Li, J., Feßler, A. T., Zhang, R., Wu, C., & Shen, J. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw040 · Cited by 115
Raven, K. E., Reuter, S., Reynolds, R., Brodrick, H. J., Russell, J. E., Török, M. E., Parkhill, J., & Peacock, S. J. (2016) · Genome Research · doi:10.1101/gr.204024.116 · Cited by 114
Effect of divalent cations on the structure of the antibiotic daptomycin
Ho, S. W., Jung, D., Calhoun, J. R., et al. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0227-2 · Cited by 112
Shukla, B. S., Shelburne, S. A., Reyes, K., Kamboj, M., Lewis, J. D., Rincón, S., Reyes, J., Carvajal, L. P., Panesso, D., Sifri, C. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw173 · Cited by 106
Tedim, A. P., Ruíz-Garbajosa, P., Corander, J., Rodríguez, C. M., Cantón, R., Willems, R. J. L., Baquero, F., & Coque, T. M. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03661-14 · Cited by 104
Self-citationAdaptation of Enterococcus faecalis to Daptomycin Reveals an Ordered Progression to Resistance
Miller, C. A., Kong, J., Tran, T. T., Arias, C. A., Saxer, G., & Shamoo, Y. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-13 · Cited by 103
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic
Eliopoulos, G. M., Thauvin, C., Gerson, B., & Moellering, R. C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.357 · Cited by 102
Tedizolid for the Management of Human Infections: In Vitro Characteristics
Locke, J. B., Zurenko, G. E., Shaw, K. J., & Bartizal, K. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit616 · Cited by 101 · cited 1×
“…received enormous attention, as it is capable of conferring resistance to at least fi ve classes of antibiotics, including linezolid (but not tedizolid); it has been detected in various bacterial species and genera (Locke et al., 2014; Long et al., 2006; Schwarz et al., 2000; Shen et al., 2013).”
BackgroundLiu, Y., Wang, Y., Schwarz, Š., Li, Y., Shen, Z., Zhang, Q., Wu, C., & Shen, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01605-12 · Cited by 101
Hall, A. D., Steed, M. E., Arias, C. A., Murray, B. E., & Rybak, M. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06439-11 · Cited by 101
Antibiotic Resistance ABC-F Proteins: Bringing Target Protection into the Limelight
Sharkey, L. K. R., & O’Neill, A. J. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00251 · Cited by 101
RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host
Honsa, E. S., Cooper, V. S., Mhaissen, M. N., Frank, M. W., Shaker, J., Iverson, A., Rubnitz, J. E., Hayden, R. T., Lee, R. E., Jr., Rock, C. O., et al. (2017) · mBio · doi:10.1128/mbio.02124-16 · Cited by 99
Muraih, J. K., Harris, J., Taylor, S. D., & Palmer, M. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.027 · Cited by 97
Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
Kainer, M. A., Devasia, R. A., Jones, T. F., Simmons, B. P., Melton, K., Chow, S., Broyles, J., Moore, K. L., Craig, A. S., & Schaffner, W. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1307.070019 · Cited by 96
Interaction of Daptomycin with Lipid Bilayers: A Lipid Extracting Effect
Chen, Y.-F., Sun, T.-L., Sun, Y., & Huang, H. W. (2014) · Biochemistry · doi:10.1021/bi500779g · Cited by 95
Reyes, J., Panesso, D., Tran, T. T., Mishra, N. N., Cruz, M. R., Munita, J. M., Singh, K. V., Yeaman, M. R., Murray, B. E., Shamoo, Y., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu602 · Cited by 94
Whang, D. W., Miller, L. G., Partain, N. M., & McKinnell, J. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-13 · Cited by 91
Fines, M., & Leclercq, R. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.797 · Cited by 91
Daptomycin forms cation- and size-selective pores in model membranes
Zhang, T., Muraih, J. K., MacCormick, B., Silverman, J. A., & Palmer, M. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.014 · Cited by 90
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
Casapao, A. M., Kullar, R., Davis, S. L., Levine, D. P., Zhao, J. J., Potoski, B. A., Goff, D. A., Crank, C. W., Segreti, J., Sakoulas, G., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00526-13 · Cited by 88
Gawryszewska, I., Żabicka, D., Hryniewicz, W., & Sadowy, E. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2934-7 · Cited by 88
Self-citationMendes, R. E., Castanheira, M., Farrell, D. J., Flamm, R. K., Sader, H. S., & Jones, R. N. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw319 · Cited by 87
Werner, G., Gfrörer, S., Fleige, C., Witte, W., & Klare, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn065 · Cited by 84
Self-citationZhang, Y., Du, M., Chang, Y., Chen, L., & Zhang, Q. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0231-y · Cited by 81
NMR structural studies of the antibiotic lipopeptide daptomycin in DHPC micelles
Scott, W. R. P., Baek, S. B., Jung, D., Hancock, R. E. W., & Straus, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.034 · Cited by 78
Sivertsen, A., Pedersen, T., Larssen, K. W., Bergh, K., Rønning, T. G., Radtke, A., & Hegstad, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00286-16 · Cited by 78
Self-citationJung, D., Powers, J.-P. S., Straus, S. K., & Hancock, R. E. W. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.04.004 · Cited by 77
Pfaller, M. A., Mendes, R. E., Streit, J. M., Hogan, P. A., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00609-17 · Cited by 75
Mechanisms of Resistance to Daptomycin in Enterococcus faecium
Montero, C. I., Stock, F., & Murray, P. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-07 · Cited by 74
Hoban, D. J., Reinert, R. R., Bouchillon, S. K., & Dowzicky, M. J. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0085-1 · Cited by 73
Mendes, R. E., Hogan, P. A., Jones, R. N., Sader, H. S., & Flamm, R. K. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw052 · Cited by 73
Chen, H., Wu, W., Ni, M., Liu, Y., Zhang, J., Xia, F., He, W., Wang, Q., Wang, Z., Cao, B., et al. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.008 · Cited by 71
Genomic Analysis of Reduced Susceptibility to Tigecycline in Enterococcus faecium
Cattoir, V., Isnard, C., Cosquer, T., Odhiambo, A., Bucquet, F., Guérin, F., & Giárd, J.-C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04174-14 · Cited by 71
Self-citationMunita, J. M., Tran, T. T., Diaz, L., Panesso, D., Reyes, J., Murray, B. E., & Arias, C. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00021-13 · Cited by 70 · cited 1×
“High levels of MICs can be reached when additional mutations occur in gdpD and cls that alter the phospholipid content of the cell membrane (Arias et al., 2011; Mishra et al., 2012; Munita et al., 2013; Reyes et al., 2015; Tran et al., 2015, 2013b).”
BackgroundCui, L., Wang, Y., Lv, Y., Wang, S., Song, Y., Li, Y., Liu, J., Xue, F., Yang, W., & Zhang, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01256-16 · Cited by 69
Tamang, M. D., Moon, D. C., Kim, S.-R., Kang, H. Y., Lee, K., Nam, H.-M., Jang, G.-C., Lee, H.-S., Jung, S.-C., & Lim, S. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.01.035 · Cited by 67
Kumaraswami, M., Schuman, J. T., Seo, S. M., Kaatz, G. W., & Brennan, R. G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1046 · Cited by 66
Seedat, J., Zick, G., Klare, I., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00518-06 · Cited by 66
Werth, B. J., Steed, M. E., Ireland, C. E., Tran, T. T., Nonejuie, P., Murray, B. E., Rose, W. E., Sakoulas, G., Pogliano, J., Arias, C. A., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00098-14 · Cited by 66
Humphries, R. M., Kelesidis, T., Tewhey, R., Rose, W. E., Schork, N. J., Nizet, V., & Sakoulas, G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01318-12 · Cited by 66
Vancomycin-Variable Enterococci Can Give Rise to Constitutive Resistance during Antibiotic Therapy
Thaker, M., Kalan, L., Waglechner, N., Eshaghi, A., Patel, S. N., Poutanen, S. M., Willey, B. M., Coburn, B. A., McGeer, A., Low, D. E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04490-14 · Cited by 65
Cafini, F., Nguyen, L. T. T., Higashide, M., Román, F., Prieto, J., & Morikawa, K. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv391 · Cited by 65
Pfaller, M. A., Mendes, R. E., Streit, J. M., Hogan, P. A., & Flamm, R. K. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx251 · Cited by 65
Klare, I., Fleige, C., Geringer, U., Thürmer, A., Bender, J. K., Mutters, N. T., Mischnik, A., & Werner, G. (2015) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2015.02.007 · Cited by 62
Self-citationRasmussen, B. A., Gluzman, Y., & Tally, F. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.7.1658 · Cited by 62
Bender, J. K., Fleige, C., Lange, D. A., Klare, I., & Werner, G. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.009 · Cited by 60
Self-citationLinezolid resistance in Enterococcus faecium isolated in Ontario, Canada
PATEL, S. N., Memari, N., Shahinas, D., Toye, B. W., Jamieson, F., & Farrell, D. J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.08.012 · Cited by 59
Lellek, H., Franke, G. C., Ruckert, C., Wolters, M., Wolschke, C., Christner, M., Büttner, H., Alawi, M., Kröger, N., & Rohde, H. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.09.005 · Cited by 51
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02684-13 · Cited by 47
Rising Vancomycin-Resistant Enterococcus Infections in Hospitalized Children in the United States
Adams, D. J., Eberly, M. D., Goudie, A., & Nylund, C. M. (2016) · Hospital Pediatrics · doi:10.1542/hpeds.2015-0196 · Cited by 47
Vega, S., & Dowzicky, M. J. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0222-0 · Cited by 46
Niebel, M. O., Quick, J., Prieto, A. M. G., Hill, R. L. R., Pike, R., Huber, D., David, M. D., Hornsey, M., Wareham, D. W., Oppenheim, B. A., et al. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.009 · Cited by 45
Lupien, A., Gingras, H., Leprohon, P., & Ouellette, M. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv211 · Cited by 45
Taylor, R., Butt, K., Scott, B., Zhang, T., Muraih, J. K., Mintzer, E. A., Taylor, S. D., & Palmer, M. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.05.020 · Cited by 44
Zhao, M., Liang, L., Ji, L., Chen, D., Zhang, Y., Zhu, Y., & Patel, K. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.010 · Cited by 44
Coburn, B. A., Low, D. E., Patel, S. N., Poutanen, S. M., Shahinas, D., Eshaghi, A., Willey, B. M., & McGeer, A. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03579-13 · Cited by 43
Panesso, D., Reyes, J., Gaston, E. P., Deal, M., Londoño, A., Nigo, M., Munita, J. M., Miller, W. R., Shamoo, Y. E., Tran, T. T., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01073-15 · Cited by 42
Wang, X., Davlieva, M. G., Reyes, J., Panesso, D., Arias, C. A., & Shamoo, Y. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01422-16 · Cited by 42
Tedim, A. P., Ruíz-Garbajosa, P., Rodríguez, M. C., Rodríguez-Baños, M., Lanza, V. F., Derdoy, L., Zurita, G. C., Loza, E., Cantón, R., Baquero, F., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw366 · Cited by 40
Self-citationTherapeutic options for vancomycin-resistant enterococcal bacteremia
Barber, K. E., King, S. T., Stover, K. R., & Pogue, J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1001839 · Cited by 38
Guo, D., Liu, Y., Han, C., Chen, Z., & Ye, X. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173624 · Cited by 38
Zhang, T., Muraih, J. K., Mintzer, E. A., Tishbi, N., Desert, C., Silverman, J. A., Taylor, S. D., & Palmer, M. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.10.008 · Cited by 35
DiPippo, A. J., Tverdek, F. P., Tarrand, J. J., Munita, J. M., Tran, T. T., Arias, C. A., Shelburne, S. A., & Aitken, S. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.11.004 · Cited by 35
Chacko, K., Sullivan, M. J., Beckford, C., Altman, D. R., Ciferri, B., Pak, T. R., Sebra, R., Kasarskis, A., Hamula, C. L. A., & van Bakel, H. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02007-17 · Cited by 33
Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX
Hansen, T. A., Pedersen, M. S., Nielsen, L. G., Ma, C. M. G., Søes, L. M., Worning, P., Østergaard, C., Westh, H., Pinholt, M., & Schønning, K. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky308 · Cited by 32
Self-citationStudy Group, Kresken, M., Becker, K., Seifert, H., Leitner, E., Körber-Irrgang, B., von Eiff, C., & Löschmann, P. A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1197-y · Cited by 30
Rampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection
Beabout, K., Hammerstrom, T. G., Wang, T. T., Bhatty, M., Christie, P. J., Saxer, G., & Shamoo, Y. E. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv133 · Cited by 29
Sinel, C., Cosquer, T., Auzou, M., Goux, D., Giárd, J.-C., & Cattoir, V. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw229 · Cited by 28
Self-citationWeisser, M., Oostdijk, E. A. N., Willems, R. J. L., Bonten, M. J. M., Frei, R., Elzi, L., Halter, J. P., Widmer, A. F., & Top, J. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-68 · Cited by 26
Tedizolid susceptibility in linezolid- and vancomycin-resistant Enterococcus faecium isolates
Klupp, E.-M., Both, A., Campos, C. E. B., Büttner, H., König, C., Christopeit, M., Christner, M., Aepfelbacher, M., & Rohde, H. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2747-0 · Cited by 26
González-Ruiz, A., Gargalianos-Kakolyris, P., Timerman, A., Sarma, J., Ramallo, V. J. G., Bouylout, K., Trostmann, U., Pathan, R. B., & Hamed, K. A. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0220-6 · Cited by 25
Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient
Cordina, C. M., Hill, R., Deshpande, A., Hood, J., & Inkster, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks122 · Cited by 25
O'Driscoll, C., Murphy, V., Doyle, O., Wrenn, C., Flynn, A. J., O’Flaherty, N., Fenelon, L. E., Schaffer, K., & FitzGerald, S. F. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.09.006 · Cited by 24
Self-citationEmergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections
Bassetti, M., Farrel, P. A., Callan, D. A., et al. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00090-6 · Cited by 24
Detection of the optrA gene in a clinical ST16 Enterococcus faecalis isolate in Denmark
Jensen, V. V. S., Roer, L., Justesen, U. S., Hansen, F., Møller, J. K., Hasman, H., & Hammerum, A. M. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.05.002 · Cited by 22
Self-citationPericàs, J. M., García-de-la-Mària, C., Brunet, M., Armero, Y., García-González, J. A., Casals, G., Almela, M., Quintana, E., Falces, C., Ninot, S. P. I., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx016 · Cited by 20
Wang, G., Kamalakaran, S., Dhand, A., Huang, W., Ojaimi, C., Zhuge, J., Yee, L. L., Mayigowda, P., Surendraiah, P. K. M., Dimitrova, N., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02683-14 · Cited by 18
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2015) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2015.04.003 · Cited by 17
Kresken, M., Leitner, E., Seifert, H., Peters, G., & von Eiff, C. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0725-5 · Cited by 17
Seifert, H., & Dowzicky, M. J. (2009) · Chemotherapy · doi:10.1159/000220245 · Cited by 17
Jung, Y., Lee, Y. S., Lee, S., Yoo, J. S., Yoo, J. I., Kim, H. S., Kim, O., & Yu, J.-Y. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.06.012 · Cited by 16
Aznar, J., Lepe, J. A., & Dowzicky, M. J. (2012) · Journal of Chemotherapy · doi:10.1179/1120009x12z.00000000016 · Cited by 16
Matono, T., Hayakawa, K., Hirai, R., Tanimura, A., Yamamoto, K., Fujiya, Y., Mawatari, M., Kutsuna, S., Takeshita, N., Mezaki, K., et al. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2003-9 · Cited by 16
Marco, F., & Dowzicky, M. J. (2016) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.02.005 · Cited by 15
Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates
Sinel, C., Jaussaud, C., Auzou, M., Giárd, J.-C., & Cattoir, V. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.07.006 · Cited by 11
Self-citationCogo, A., González-Ruiz, A., Pathan, R. B., & Hamed, K. A. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0074-x · Cited by 10
Freitas, A. R., Novais, C., Read, A., Alves, V., & Peixe, L. M. S. V. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.03.011 · Cited by 9
Self-citationStefani, S., & Dowzicky, M. J. (2016) · Pharmaceuticals · doi:10.3390/ph9040074 · Cited by 8
Sorlózano, A., Panesso, D., Navarro‐Marí, J. M., Arias, C. A., & Fernández, J. G. (2015) · PubMed · Cited by 6
Sandoval, N., Grau, S., Sorlí, L., Montero, M., Esteve, E., & Horcajada, J. P. (2015) · Future Microbiology · doi:10.2217/fmb.15.41 · Cited by 6
Cited by
Denissen, J., Reyneke, B., Waso-Reyneke, M., Havenga, B., Barnard, T., Khan, S., & Khan, W. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114006 · Cited by 395
Metadata
- Authors
- Bender, J. K., Cattoir, V., Hegstad, K., Sadowy, E., Coque, T. M., Westh, H., Hammerum, A. M., Schaffer, K., Burns, K., Murchan, S., Novais, C., Freitas, A. R., Peixe, L., Del Grosso, M., Pantosti, A., & Werner, G.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 40
- Pages
- 25-39
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2898922831
- Cited by
- 281
- References
- 167
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.